Skip to main content
Screener/Healthcare/Biotechnology

STOK — Stoke Therapeutics, Inc.

NASDAQ
$33.22+0.49 (+1.51%)
Mid CapUnder $50Healthcare
$8.30
$40.22
$32.42
$33.60
EPS (TTM)$-0.14
P/E Ratio-282.66
Dividend Yield—
Market Cap$2.11B
Volume305K
Prev Close$32.72
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$1.4M-$57.9M$-0.9924.8%-4132.2%
Q3 '25$10.6M-$38.3M$-0.6590.7%-360.7%
Q2 '25$13.8M-$23.5M$-0.40100.0%-170.0%
Q1 '25$158.6M$112.9M$1.90100.0%71.2%
Q4 '24$22.6M-$10.5M$-0.18100.0%-46.4%
Q3 '24$4.9M-$26.4M$-0.47100.0%-540.0%
Q2 '24$4.8M-$25.7M$-0.4677.0%-531.9%
Q1 '24$4.2M-$26.4M$-0.5773.6%-625.6%
Get Your Daily Market Recap